Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-466
Closed -$134K 109
2023
Q4
$134K Buy
+466
New +$127K 0.04% 118
2023
Q3
Sell
-455
Closed -$101K 98
2023
Q2
$101K Buy
+455
New +$106K 0.03% 132
2022
Q4
Sell
-399
Closed -$90K 91
2022
Q3
$90K Buy
399
+3
+0.8% +$727 0.03% 109
2022
Q2
$96K Sell
396
-150
-27% -$36.8K 0.03% 106
2022
Q1
$132K Sell
546
-22
-4% -$5.05K 0.04% 96
2021
Q4
$128K Buy
568
+5
+0.9% +$1.05K 0.04% 99
2021
Q3
$120K Buy
+563
New +$130K 0.04% 102
2020
Q1
Sell
-1,246
Closed -$300K 26
2019
Q4
$300K Sell
1,246
-15
-1% -$3.31K 0.15% 40
2019
Q3
$244K Buy
1,261
+30
+2% +$5.76K 0.14% 45
2019
Q2
$227K Buy
1,231
+157
+15% +$28.1K 0.14% 49
2019
Q1
$204K Buy
+1,074
New +$205K 0.13% 49

Other funds holding AMGN

O'Dell Group's AMGN Position: Q1 2024 in Review

O'Dell Group sold out of Amgen (AMGN) in Q1 2024, closing a stake of 466 shares — an estimated $134K sold.

O'Dell Group first reported a position in AMGN in Q1 2019 and held it in 11 quarters. The position peaked at $300K in Q4 2019. 2,721 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • O'Dell Group reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • O'Dell Group sold 466 Amgen shares in Q1 2024, an estimated $134K.
  • O'Dell Group first reported a position in Amgen in Q1 2019 and held it in 11 quarters.
  • O'Dell Group's Amgen position peaked at $300K in Q4 2019.
  • 2,721 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.